Status:
COMPLETED
ReIMAGINE Prostate Cancer Screening
Lead Sponsor:
University College, London
Collaborating Sponsors:
Medical Research Council
Cancer Research UK
Conditions:
Prostate Cancer Screening
Prostate Cancer
Eligibility:
MALE
50-75 years
Phase:
NA
Brief Summary
Single site study to assess the feasibility of prostate cancer screening using an invitation for a prostate MRI scan via GP practices. This feasibility study will assess the acceptability of an MRI as...
Detailed Description
ReIMAGINE Prostate cancer screening is a single site screening study to assess the feasibility of MRI as a screening tool for prostate care and determine the prevalence of MRI defined suspicious lesio...
Eligibility Criteria
Inclusion
- Men aged 50-75
- No prior prostate cancer diagnosis / treatment
- Willing and able to provide written informed consent.
Exclusion
- Contraindication for MRI scanning (as assessed by the MRI safety questionnaire of the PET/MRI department) which includes but is not limited to: Intracranial aneurysm clips or other metallic objects; Intra-orbital metal fragments that have not been removed; Pacemakers or other implanted cardiac rhythm management devices and non-MRI compatible heart valves; Inner ear implants; and History of claustrophobia
- Men who require assisted living e.g. care home living
- Dementia or other neurological condition meaning participant lacks the capacity to consent.
Key Trial Info
Start Date :
October 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT04063566
Start Date
October 21 2019
End Date
September 30 2021
Last Update
October 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospital
London, United Kingdom, NW1 2PG